Gene Symbol | Gene ID | Gene Info |
---|---|---|
Barhl1
|
ENSMUSG00000026805.8 | BarH like homeobox 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_28911293_28912310 | Barhl1 | 694 | 0.661675 | 0.42 | 8.9e-04 | Click! |
chr2_28910187_28910661 | Barhl1 | 2071 | 0.286980 | 0.38 | 3.0e-03 | Click! |
chr2_28914529_28916444 | Barhl1 | 19 | 0.975057 | 0.35 | 5.5e-03 | Click! |
chr2_28907958_28910057 | Barhl1 | 3488 | 0.211822 | 0.32 | 1.3e-02 | Click! |
chr2_28912503_28913308 | Barhl1 | 410 | 0.829145 | 0.32 | 1.3e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr4_116223265_116224130 | 2.44 |
Pik3r3 |
phosphoinositide-3-kinase regulatory subunit 3 |
2001 |
0.23 |
chr6_134886811_134888239 | 2.30 |
Gpr19 |
G protein-coupled receptor 19 |
243 |
0.87 |
chr5_88583963_88584847 | 2.25 |
Rufy3 |
RUN and FYVE domain containing 3 |
611 |
0.7 |
chr13_83719687_83720586 | 2.08 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1245 |
0.36 |
chr9_41585694_41587243 | 2.03 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1301 |
0.29 |
chr10_125967796_125968797 | 2.01 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
2043 |
0.45 |
chr2_181768465_181769553 | 1.92 |
Myt1 |
myelin transcription factor 1 |
1497 |
0.33 |
chrX_88114468_88114695 | 1.92 |
Il1rapl1 |
interleukin 1 receptor accessory protein-like 1 |
1064 |
0.64 |
chr3_86542542_86543253 | 1.86 |
Lrba |
LPS-responsive beige-like anchor |
864 |
0.63 |
chr13_83721518_83722206 | 1.70 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
481 |
0.73 |
chr4_105160308_105161104 | 1.69 |
Plpp3 |
phospholipid phosphatase 3 |
3359 |
0.33 |
chr19_38263947_38265363 | 1.66 |
Lgi1 |
leucine-rich repeat LGI family, member 1 |
5 |
0.97 |
chr10_18470218_18471289 | 1.63 |
Nhsl1 |
NHS-like 1 |
772 |
0.72 |
chr4_11964013_11964651 | 1.63 |
Pdp1 |
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
1489 |
0.31 |
chr5_103209022_103210413 | 1.61 |
Mapk10 |
mitogen-activated protein kinase 10 |
705 |
0.75 |
chr8_45508499_45509041 | 1.57 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
852 |
0.61 |
chr2_92188323_92189316 | 1.56 |
Phf21a |
PHD finger protein 21A |
2354 |
0.24 |
chr9_71892666_71893902 | 1.55 |
Tcf12 |
transcription factor 12 |
2701 |
0.17 |
chr5_47987427_47987688 | 1.52 |
Slit2 |
slit guidance ligand 2 |
285 |
0.89 |
chr12_117149811_117150131 | 1.50 |
Gm10421 |
predicted gene 10421 |
1244 |
0.61 |
chr17_68881822_68882051 | 1.49 |
Gm49949 |
predicted gene, 49949 |
37911 |
0.15 |
chr12_49390931_49392462 | 1.49 |
3110039M20Rik |
RIKEN cDNA 3110039M20 gene |
1037 |
0.42 |
chr9_37143090_37143295 | 1.41 |
Pknox2 |
Pbx/knotted 1 homeobox 2 |
2468 |
0.19 |
chr5_126768981_126769769 | 1.41 |
Gm33347 |
predicted gene, 33347 |
42091 |
0.14 |
chr1_25832036_25832712 | 1.38 |
Gm9884 |
predicted gene 9884 |
1717 |
0.22 |
chr10_90830503_90831025 | 1.35 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
921 |
0.56 |
chr13_44946654_44947258 | 1.34 |
Dtnbp1 |
dystrobrevin binding protein 1 |
188 |
0.96 |
chr3_29432333_29432484 | 1.30 |
Mir551b |
microRNA 551b |
15585 |
0.23 |
chr2_116067707_116068579 | 1.29 |
G630016G05Rik |
RIKEN cDNA G630016G05 gene |
175 |
0.85 |
chr9_60886449_60886699 | 1.27 |
Uaca |
uveal autoantigen with coiled-coil domains and ankyrin repeats |
20429 |
0.17 |
chr4_13747506_13748460 | 1.23 |
Runx1t1 |
RUNX1 translocation partner 1 |
3314 |
0.37 |
chr9_41611530_41612990 | 1.23 |
Gm48737 |
predicted gene, 48737 |
6732 |
0.12 |
chr1_14308374_14310407 | 1.21 |
Eya1 |
EYA transcriptional coactivator and phosphatase 1 |
446 |
0.88 |
chr15_26310303_26310668 | 1.20 |
Marchf11 |
membrane associated ring-CH-type finger 11 |
1421 |
0.58 |
chr13_63560468_63561467 | 1.19 |
Ptch1 |
patched 1 |
2848 |
0.2 |
chr4_25798002_25798171 | 1.19 |
Fut9 |
fucosyltransferase 9 |
1769 |
0.36 |
chr18_25750468_25751272 | 1.18 |
Celf4 |
CUGBP, Elav-like family member 4 |
1822 |
0.41 |
chr2_18042311_18043883 | 1.18 |
Skida1 |
SKI/DACH domain containing 1 |
1475 |
0.25 |
chr17_7025121_7026216 | 1.17 |
Gm1604b |
predicted gene 1604b |
100 |
0.96 |
chr2_178143444_178143670 | 1.17 |
Phactr3 |
phosphatase and actin regulator 3 |
1624 |
0.46 |
chr4_22485088_22485284 | 1.16 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
3180 |
0.21 |
chr2_65920844_65921070 | 1.15 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
9180 |
0.22 |
chr2_32428080_32429746 | 1.13 |
Slc25a25 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 |
1839 |
0.19 |
chr8_54957303_54957776 | 1.12 |
Gm45263 |
predicted gene 45263 |
2280 |
0.24 |
chr13_78206997_78207615 | 1.12 |
A830082K12Rik |
RIKEN cDNA A830082K12 gene |
4519 |
0.16 |
chr2_92187716_92188153 | 1.10 |
Phf21a |
PHD finger protein 21A |
1469 |
0.36 |
chr14_32317593_32317850 | 1.10 |
Gm48914 |
predicted gene, 48914 |
264 |
0.86 |
chr17_8100471_8101617 | 1.09 |
Gm1604a |
predicted gene 1604A |
159 |
0.95 |
chr5_128431467_128431733 | 1.09 |
Tmem132d |
transmembrane protein 132D |
1477 |
0.37 |
chr5_37244380_37244680 | 1.07 |
Crmp1 |
collapsin response mediator protein 1 |
1234 |
0.48 |
chr5_57723598_57724600 | 1.07 |
Gm42635 |
predicted gene 42635 |
294 |
0.83 |
chr13_31814307_31814974 | 1.04 |
Foxc1 |
forkhead box C1 |
8007 |
0.17 |
chr16_63862649_63862946 | 1.02 |
Epha3 |
Eph receptor A3 |
616 |
0.83 |
chr16_21166281_21166432 | 1.02 |
Teddm3 |
transmembrane epididymal family member 3 |
12356 |
0.16 |
chr12_106226760_106227822 | 1.02 |
Gm24986 |
predicted gene, 24986 |
6216 |
0.26 |
chr1_184441074_184441672 | 1.01 |
2900092O11Rik |
RIKEN cDNA 2900092O11 gene |
1607 |
0.43 |
chr13_109442519_109443753 | 1.00 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
953 |
0.73 |
chr1_99772154_99773556 | 0.99 |
Cntnap5b |
contactin associated protein-like 5B |
90 |
0.98 |
chr3_38883838_38884029 | 0.99 |
Fat4 |
FAT atypical cadherin 4 |
3007 |
0.29 |
chr8_10155630_10156153 | 0.98 |
Myo16 |
myosin XVI |
1923 |
0.43 |
chr8_67973559_67974885 | 0.98 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
352 |
0.89 |
chr12_118852025_118852421 | 0.97 |
Sp8 |
trans-acting transcription factor 8 |
4637 |
0.25 |
chr1_12692796_12693687 | 0.97 |
Sulf1 |
sulfatase 1 |
709 |
0.67 |
chr18_65583033_65584701 | 0.97 |
Zfp532 |
zinc finger protein 532 |
70 |
0.95 |
chr2_64092860_64093848 | 0.96 |
Fign |
fidgetin |
4634 |
0.37 |
chr1_78186833_78187893 | 0.95 |
Pax3 |
paired box 3 |
9475 |
0.23 |
chr18_46197458_46197732 | 0.95 |
Trim36 |
tripartite motif-containing 36 |
1223 |
0.36 |
chr3_31099281_31100546 | 0.94 |
Skil |
SKI-like |
3080 |
0.26 |
chr12_95699008_95699374 | 0.94 |
Flrt2 |
fibronectin leucine rich transmembrane protein 2 |
3834 |
0.21 |
chr7_137318563_137320070 | 0.94 |
Ebf3 |
early B cell factor 3 |
4871 |
0.21 |
chr4_62966572_62967137 | 0.93 |
Zfp618 |
zinc finger protein 618 |
1280 |
0.42 |
chr5_37825667_37826469 | 0.93 |
Msx1 |
msh homeobox 1 |
1485 |
0.42 |
chr10_49785211_49786117 | 0.93 |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
2255 |
0.25 |
chr3_55782570_55784448 | 0.93 |
Nbea |
neurobeachin |
19 |
0.96 |
chr1_168426195_168428871 | 0.92 |
Pbx1 |
pre B cell leukemia homeobox 1 |
3971 |
0.3 |
chr11_32001099_32002296 | 0.92 |
Nsg2 |
neuron specific gene family member 2 |
1195 |
0.52 |
chr19_14590125_14590853 | 0.92 |
Tle4 |
transducin-like enhancer of split 4 |
5050 |
0.31 |
chr15_25416075_25416310 | 0.92 |
Gm48957 |
predicted gene, 48957 |
1129 |
0.37 |
chr1_138836757_138837880 | 0.91 |
Lhx9 |
LIM homeobox protein 9 |
3659 |
0.19 |
chr14_26313384_26313715 | 0.91 |
Gm18578 |
predicted gene, 18578 |
10844 |
0.13 |
chr6_6877373_6877738 | 0.91 |
Dlx5 |
distal-less homeobox 5 |
4513 |
0.14 |
chr13_116514424_116515376 | 0.91 |
Gm47913 |
predicted gene, 47913 |
148636 |
0.04 |
chr5_43236846_43237650 | 0.90 |
Cpeb2 |
cytoplasmic polyadenylation element binding protein 2 |
67 |
0.96 |
chrX_52914554_52915519 | 0.89 |
Phf6 |
PHD finger protein 6 |
2741 |
0.19 |
chr6_94695739_94697689 | 0.89 |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
3423 |
0.29 |
chr1_132323403_132323599 | 0.89 |
Nuak2 |
NUAK family, SNF1-like kinase, 2 |
4095 |
0.14 |
chr5_13125231_13126281 | 0.88 |
Sema3a |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
163 |
0.95 |
chr8_31089411_31091663 | 0.88 |
Dusp26 |
dual specificity phosphatase 26 (putative) |
733 |
0.65 |
chr8_87956508_87957284 | 0.88 |
Zfp423 |
zinc finger protein 423 |
2699 |
0.36 |
chr11_80479429_80480178 | 0.88 |
Cdk5r1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
2747 |
0.26 |
chr11_120187408_120187862 | 0.88 |
2810410L24Rik |
RIKEN cDNA 2810410L24 gene |
1116 |
0.34 |
chr9_59071819_59071970 | 0.87 |
Neo1 |
neogenin |
35453 |
0.18 |
chr5_9623201_9623446 | 0.87 |
Gm42455 |
predicted gene 42455 |
20716 |
0.24 |
chr3_127407787_127409013 | 0.87 |
Ank2 |
ankyrin 2, brain |
554 |
0.71 |
chr2_181763361_181764530 | 0.86 |
Myt1 |
myelin transcription factor 1 |
613 |
0.66 |
chr12_89815214_89815490 | 0.86 |
Nrxn3 |
neurexin III |
2869 |
0.41 |
chr14_93887180_93887734 | 0.86 |
Pcdh9 |
protocadherin 9 |
1233 |
0.6 |
chr18_81165961_81166641 | 0.85 |
4930594M17Rik |
RIKEN cDNA 4930594M17 gene |
69765 |
0.09 |
chr9_110053895_110054422 | 0.85 |
Map4 |
microtubule-associated protein 4 |
2106 |
0.22 |
chr12_49381999_49382431 | 0.85 |
Gm34304 |
predicted gene, 34304 |
330 |
0.56 |
chr7_114657035_114657419 | 0.85 |
Calca |
calcitonin/calcitonin-related polypeptide, alpha |
20870 |
0.16 |
chr3_38480746_38481166 | 0.85 |
Ankrd50 |
ankyrin repeat domain 50 |
2135 |
0.29 |
chr3_31097203_31098928 | 0.85 |
Skil |
SKI-like |
1232 |
0.48 |
chr4_76025856_76026175 | 0.85 |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
58442 |
0.16 |
chr11_96296491_96297669 | 0.84 |
Hoxb6 |
homeobox B6 |
2091 |
0.12 |
chrX_110813716_110813994 | 0.84 |
Pou3f4 |
POU domain, class 3, transcription factor 4 |
425 |
0.82 |
chr4_91373231_91373407 | 0.83 |
Mir6402 |
microRNA 6402 |
44 |
0.8 |
chr4_153484340_153484575 | 0.83 |
Ajap1 |
adherens junction associated protein 1 |
1646 |
0.54 |
chr1_152088197_152088377 | 0.83 |
1700025G04Rik |
RIKEN cDNA 1700025G04 gene |
1683 |
0.46 |
chr6_148441933_148442246 | 0.83 |
Tmtc1 |
transmembrane and tetratricopeptide repeat containing 1 |
454 |
0.84 |
chr7_137302818_137302976 | 0.83 |
Ebf3 |
early B cell factor 3 |
11019 |
0.19 |
chr11_95122144_95122295 | 0.83 |
Dlx3 |
distal-less homeobox 3 |
2100 |
0.22 |
chr6_8659434_8659769 | 0.83 |
Ica1 |
islet cell autoantigen 1 |
11782 |
0.24 |
chr1_193897116_193897267 | 0.82 |
Gm21362 |
predicted gene, 21362 |
30182 |
0.25 |
chr3_17798321_17798878 | 0.82 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
2855 |
0.23 |
chr2_121295003_121295302 | 0.81 |
Map1a |
microtubule-associated protein 1 A |
302 |
0.75 |
chr4_88017549_88018256 | 0.81 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
14911 |
0.17 |
chr13_55496018_55496313 | 0.81 |
Dbn1 |
drebrin 1 |
8054 |
0.08 |
chr13_94912810_94913359 | 0.81 |
Otp |
orthopedia homeobox |
30484 |
0.15 |
chr14_12339117_12339550 | 0.80 |
Gm24578 |
predicted gene, 24578 |
5429 |
0.13 |
chr8_54956010_54956394 | 0.78 |
Gpm6a |
glycoprotein m6a |
1359 |
0.38 |
chr2_6868634_6869464 | 0.78 |
Celf2 |
CUGBP, Elav-like family member 2 |
2923 |
0.27 |
chr6_21989797_21990180 | 0.78 |
Cped1 |
cadherin-like and PC-esterase domain containing 1 |
3096 |
0.32 |
chr11_71984848_71984999 | 0.78 |
Gm23226 |
predicted gene, 23226 |
37832 |
0.12 |
chr9_117837070_117837361 | 0.77 |
Rbms3 |
RNA binding motif, single stranded interacting protein |
35369 |
0.18 |
chr17_17402413_17403374 | 0.77 |
Lix1 |
limb and CNS expressed 1 |
221 |
0.91 |
chr13_84063384_84064052 | 0.77 |
Gm17750 |
predicted gene, 17750 |
1054 |
0.58 |
chr9_122902673_122903816 | 0.77 |
Zkscan7 |
zinc finger with KRAB and SCAN domains 7 |
2 |
0.52 |
chr17_80945251_80945713 | 0.77 |
Tmem178 |
transmembrane protein 178 |
850 |
0.63 |
chr4_101082160_101082961 | 0.76 |
Raver2 |
ribonucleoprotein, PTB-binding 2 |
13081 |
0.15 |
chrX_155624379_155625097 | 0.76 |
Gm15155 |
predicted gene 15155 |
3 |
0.95 |
chr14_28512745_28513804 | 0.76 |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
1823 |
0.31 |
chr8_65036696_65037878 | 0.76 |
Apela |
apelin receptor early endogenous ligand |
49 |
0.68 |
chr14_65423052_65425451 | 0.76 |
Pnoc |
prepronociceptin |
909 |
0.6 |
chr11_87682349_87682639 | 0.75 |
Gm25968 |
predicted gene, 25968 |
12087 |
0.11 |
chr5_37897574_37897725 | 0.75 |
Gm20052 |
predicted gene, 20052 |
2942 |
0.3 |
chr2_31499665_31500576 | 0.75 |
Ass1 |
argininosuccinate synthetase 1 |
606 |
0.73 |
chr14_105333345_105334016 | 0.75 |
Ndfip2 |
Nedd4 family interacting protein 2 |
39134 |
0.13 |
chr15_30459904_30460844 | 0.74 |
Ctnnd2 |
catenin (cadherin associated protein), delta 2 |
2586 |
0.34 |
chr7_45220804_45220955 | 0.74 |
Tead2 |
TEA domain family member 2 |
433 |
0.57 |
chr9_112232067_112232798 | 0.74 |
Arpp21 |
cyclic AMP-regulated phosphoprotein, 21 |
69 |
0.97 |
chr6_36808050_36808542 | 0.74 |
Ptn |
pleiotrophin |
1883 |
0.46 |
chr1_77512287_77513134 | 0.73 |
Epha4 |
Eph receptor A4 |
2369 |
0.26 |
chr2_157075041_157076455 | 0.73 |
Soga1 |
suppressor of glucose, autophagy associated 1 |
3506 |
0.18 |
chr12_100907442_100908590 | 0.73 |
Gpr68 |
G protein-coupled receptor 68 |
165 |
0.92 |
chr14_100374663_100375528 | 0.73 |
Gm26367 |
predicted gene, 26367 |
43388 |
0.15 |
chr11_68383218_68383411 | 0.73 |
Ntn1 |
netrin 1 |
3512 |
0.28 |
chr1_138424195_138424346 | 0.73 |
Gm28500 |
predicted gene 28500 |
47006 |
0.14 |
chr3_129201144_129201586 | 0.73 |
Pitx2 |
paired-like homeodomain transcription factor 2 |
1396 |
0.39 |
chr19_55814783_55814978 | 0.73 |
Ppnr |
per-pentamer repeat gene |
26792 |
0.23 |
chr5_149964577_149965110 | 0.73 |
Gm21048 |
predicted gene, 21048 |
38471 |
0.11 |
chr3_18624612_18626165 | 0.72 |
Gm42944 |
predicted gene 42944 |
3226 |
0.26 |
chr6_4745269_4745497 | 0.72 |
Sgce |
sarcoglycan, epsilon |
1680 |
0.27 |
chr18_80982763_80983698 | 0.72 |
Sall3 |
spalt like transcription factor 3 |
3306 |
0.17 |
chr12_98564569_98564980 | 0.72 |
Kcnk10 |
potassium channel, subfamily K, member 10 |
9938 |
0.14 |
chr8_96455054_96456367 | 0.71 |
Gm32122 |
predicted gene, 32122 |
51848 |
0.14 |
chr10_30405795_30406409 | 0.71 |
Gm4780 |
predicted gene 4780 |
32829 |
0.18 |
chr3_88206822_88208169 | 0.71 |
Gm3764 |
predicted gene 3764 |
183 |
0.86 |
chr6_54564534_54565307 | 0.71 |
Scrn1 |
secernin 1 |
1569 |
0.36 |
chr7_62421917_62422068 | 0.71 |
Gm32061 |
predicted gene, 32061 |
1253 |
0.36 |
chr13_62855957_62856314 | 0.70 |
Fbp2 |
fructose bisphosphatase 2 |
174 |
0.92 |
chr14_103779191_103779479 | 0.70 |
Ednrb |
endothelin receptor type B |
64360 |
0.12 |
chr10_65523445_65523613 | 0.70 |
Gm4796 |
predicted gene 4796 |
11125 |
0.3 |
chr4_54950838_54951442 | 0.70 |
Zfp462 |
zinc finger protein 462 |
3164 |
0.35 |
chr2_136062179_136062393 | 0.70 |
Lamp5 |
lysosomal-associated membrane protein family, member 5 |
2855 |
0.3 |
chr2_178141581_178143125 | 0.70 |
Phactr3 |
phosphatase and actin regulator 3 |
420 |
0.88 |
chr1_163990350_163990501 | 0.70 |
BC055324 |
cDNA sequence BC055324 |
4116 |
0.17 |
chr16_44679244_44680185 | 0.70 |
Nepro |
nucleolus and neural progenitor protein |
44587 |
0.13 |
chr5_5510246_5510397 | 0.69 |
Cldn12 |
claudin 12 |
4128 |
0.19 |
chr18_54976859_54977074 | 0.69 |
Zfp608 |
zinc finger protein 608 |
13200 |
0.2 |
chr2_105678552_105679922 | 0.69 |
Pax6 |
paired box 6 |
630 |
0.68 |
chr4_116878423_116878655 | 0.69 |
Zswim5 |
zinc finger SWIM-type containing 5 |
1163 |
0.29 |
chr1_42680238_42680842 | 0.69 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
12553 |
0.13 |
chr13_84064321_84064873 | 0.69 |
Gm17750 |
predicted gene, 17750 |
175 |
0.96 |
chr1_137905059_137905412 | 0.68 |
Gm37298 |
predicted gene, 37298 |
4056 |
0.11 |
chr15_98989928_98991865 | 0.68 |
4930578M01Rik |
RIKEN cDNA 4930578M01 gene |
5002 |
0.1 |
chr17_44816046_44816197 | 0.68 |
Runx2 |
runt related transcription factor 2 |
1324 |
0.48 |
chr16_59639765_59639916 | 0.68 |
Arl6 |
ADP-ribosylation factor-like 6 |
449 |
0.58 |
chr5_98255305_98256217 | 0.68 |
Fgf5 |
fibroblast growth factor 5 |
1349 |
0.47 |
chr1_168391757_168392729 | 0.68 |
Pbx1 |
pre B cell leukemia homeobox 1 |
39261 |
0.16 |
chr12_57401254_57401405 | 0.67 |
Gm16246 |
predicted gene 16246 |
48791 |
0.13 |
chr4_136139819_136141345 | 0.67 |
Id3 |
inhibitor of DNA binding 3 |
2915 |
0.18 |
chr9_114056904_114057055 | 0.67 |
Susd5 |
sushi domain containing 5 |
161 |
0.95 |
chr15_53901822_53903009 | 0.67 |
Samd12 |
sterile alpha motif domain containing 12 |
34 |
0.98 |
chr13_84224650_84225206 | 0.67 |
Tmem161b |
transmembrane protein 161B |
286 |
0.88 |
chr1_42703141_42704653 | 0.67 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
4155 |
0.16 |
chr3_136833436_136833996 | 0.66 |
Ppp3ca |
protein phosphatase 3, catalytic subunit, alpha isoform |
977 |
0.6 |
chr7_130694408_130694559 | 0.66 |
Tacc2 |
transforming, acidic coiled-coil containing protein 2 |
1718 |
0.36 |
chr11_84042912_84043451 | 0.66 |
Synrg |
synergin, gamma |
16526 |
0.16 |
chr13_83739310_83740387 | 0.66 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
985 |
0.29 |
chr4_107681025_107681274 | 0.66 |
Dmrtb1 |
DMRT-like family B with proline-rich C-terminal, 1 |
189 |
0.91 |
chr3_121721126_121721811 | 0.66 |
Gm43823 |
predicted gene 43823 |
1934 |
0.18 |
chr3_19308789_19309348 | 0.66 |
Pde7a |
phosphodiesterase 7A |
1835 |
0.44 |
chr3_55463865_55464016 | 0.66 |
Dclk1 |
doublecortin-like kinase 1 |
1968 |
0.27 |
chr14_48741289_48741440 | 0.65 |
Gm49156 |
predicted gene, 49156 |
555 |
0.65 |
chr1_162221739_162222251 | 0.65 |
Mir214 |
microRNA 214 |
1373 |
0.34 |
chr9_61326264_61326415 | 0.65 |
B930092H01Rik |
RIKEN cDNA B930092H01 gene |
32530 |
0.15 |
chr1_90205794_90205989 | 0.65 |
Ackr3 |
atypical chemokine receptor 3 |
1885 |
0.31 |
chr10_18469102_18470206 | 0.65 |
Nhsl1 |
NHS-like 1 |
234 |
0.95 |
chrX_12071165_12071392 | 0.65 |
Bcor |
BCL6 interacting corepressor |
9275 |
0.27 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.2 | GO:1903375 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
0.6 | 1.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.5 | 1.5 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.5 | 1.4 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.4 | 1.3 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.4 | 1.6 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.4 | 1.1 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.3 | 1.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.3 | 1.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.3 | 0.8 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.3 | 1.8 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.3 | 0.5 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
0.2 | 0.7 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.2 | 1.1 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.2 | 0.2 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.2 | 0.9 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.2 | 0.8 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.2 | 0.2 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.2 | 0.6 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.2 | 1.2 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.2 | 0.8 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 0.6 | GO:0021586 | pons maturation(GO:0021586) |
0.2 | 0.5 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.2 | 0.5 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.2 | 0.2 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.2 | 0.8 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.2 | 0.7 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.2 | 0.2 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
0.2 | 0.5 | GO:0008050 | female courtship behavior(GO:0008050) |
0.2 | 1.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.2 | 0.8 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.2 | 0.5 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.1 | 0.4 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.6 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.1 | 0.5 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.1 | 0.7 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.1 | 0.3 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.1 | 0.5 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.5 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.4 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.1 | 0.4 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.1 | 0.4 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.1 | 0.4 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.1 | 0.6 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 0.6 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.6 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.6 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.1 | 0.3 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
0.1 | 0.2 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.5 | GO:0060594 | mammary gland specification(GO:0060594) |
0.1 | 0.8 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.1 | 0.2 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 0.3 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.1 | 0.4 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.1 | 0.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.3 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.3 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.1 | 0.1 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.1 | 0.8 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.9 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.4 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.3 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.3 | GO:0072017 | distal tubule development(GO:0072017) |
0.1 | 0.4 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.4 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.1 | 0.2 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.1 | 0.6 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.1 | 0.5 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 0.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.5 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.1 | 0.3 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.1 | 0.1 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.1 | 0.1 | GO:0097106 | postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) |
0.1 | 0.4 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.2 | GO:0007494 | midgut development(GO:0007494) |
0.1 | 0.2 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.1 | 0.2 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.1 | 0.1 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.6 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.1 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.1 | 0.2 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.1 | 0.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 | 0.6 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.7 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 0.6 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 1.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 0.1 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.7 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.1 | 0.2 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.1 | 0.4 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.1 | 0.1 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.1 | 0.4 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 0.5 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.3 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.3 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.3 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.3 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 0.1 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.1 | 0.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.3 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.1 | 0.2 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.1 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.6 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.1 | 0.1 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.1 | 0.3 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.8 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.3 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 0.1 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
0.1 | 0.3 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.1 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.1 | 0.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.2 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 1.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.1 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.1 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.2 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.1 | 0.2 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.3 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.2 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 0.5 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 0.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.2 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.2 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.1 | 0.7 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.0 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.0 | 0.5 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.5 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.0 | 0.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.1 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.0 | 0.3 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.0 | 0.6 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.0 | 0.0 | GO:0072079 | nephron tubule formation(GO:0072079) |
0.0 | 0.3 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.0 | 0.3 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.0 | 0.8 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.0 | 0.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.1 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.0 | 0.4 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.0 | 0.2 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.0 | 0.3 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 1.0 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.2 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.0 | 0.0 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
0.0 | 0.4 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.0 | 0.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.0 | 0.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.0 | 0.1 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.0 | 0.1 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.0 | 0.5 | GO:0007614 | short-term memory(GO:0007614) |
0.0 | 0.1 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.0 | 0.0 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.0 | 0.1 | GO:0072093 | metanephric renal vesicle formation(GO:0072093) |
0.0 | 0.1 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.0 | 0.3 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.0 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.0 | 0.2 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.0 | 0.0 | GO:0090427 | activation of meiosis(GO:0090427) |
0.0 | 0.1 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.1 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.0 | 0.5 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.0 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.0 | 0.1 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.0 | 0.6 | GO:0002385 | mucosal immune response(GO:0002385) |
0.0 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.1 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.0 | 0.1 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.0 | 0.1 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.4 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.0 | 0.3 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.0 | 0.2 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 0.0 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.0 | 0.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.4 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.0 | 0.1 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 0.1 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.0 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.1 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.0 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.3 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.4 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.0 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.0 | 0.2 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.1 | GO:0033153 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.0 | 0.3 | GO:0060074 | synapse maturation(GO:0060074) |
0.0 | 0.1 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.0 | 0.3 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.7 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.0 | 0.1 | GO:0060613 | fat pad development(GO:0060613) |
0.0 | 0.1 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.0 | 0.1 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.0 | 0.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.1 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.4 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.0 | 0.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.3 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.0 | 0.2 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.0 | 0.3 | GO:0042711 | maternal behavior(GO:0042711) |
0.0 | 0.1 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.0 | 0.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.1 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.0 | 0.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.0 | 0.1 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.0 | 0.0 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.0 | 0.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.0 | 0.1 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.0 | 0.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.0 | 0.2 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 0.0 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.0 | 0.1 | GO:0036233 | glycine import(GO:0036233) |
0.0 | 0.1 | GO:0007440 | foregut morphogenesis(GO:0007440) |
0.0 | 0.2 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.4 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.0 | 0.0 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.0 | 0.2 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.0 | 0.1 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.1 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.0 | 0.1 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 1.0 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.0 | 0.0 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
0.0 | 0.1 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.0 | 0.5 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.0 | 0.1 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.0 | 0.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.0 | 0.5 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.0 | 1.4 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.0 | 0.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.1 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.0 | 0.0 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.0 | 0.1 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.1 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.0 | 0.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.3 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.2 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.0 | 0.5 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.2 | GO:0035137 | embryonic hindlimb morphogenesis(GO:0035116) hindlimb morphogenesis(GO:0035137) |
0.0 | 0.2 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.0 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.0 | 2.8 | GO:0007411 | axon guidance(GO:0007411) |
0.0 | 0.1 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.0 | 0.1 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.0 | 0.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.0 | 0.1 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.3 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.2 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.0 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.0 | 0.1 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.0 | 0.3 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.0 | 0.0 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.0 | 0.2 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.0 | 0.0 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.0 | 0.4 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.2 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.0 | 0.2 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.0 | 0.5 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.3 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) |
0.0 | 0.1 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 0.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.7 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.4 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.1 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.0 | 0.0 | GO:0021557 | oculomotor nerve development(GO:0021557) trochlear nerve development(GO:0021558) |
0.0 | 0.1 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.0 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.0 | 0.0 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.0 | GO:0061196 | fungiform papilla development(GO:0061196) |
0.0 | 0.4 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 0.1 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.0 | 0.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.0 | 0.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.0 | 0.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.2 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.0 | 0.1 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.0 | 0.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.0 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.0 | 0.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.3 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.0 | 0.0 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.0 | 0.4 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.1 | GO:2000822 | regulation of fear response(GO:1903365) positive regulation of fear response(GO:1903367) regulation of behavioral fear response(GO:2000822) positive regulation of behavioral fear response(GO:2000987) |
0.0 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.0 | GO:0052151 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
0.0 | 0.0 | GO:0006114 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
0.0 | 0.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.0 | 0.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.0 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.0 | GO:0048143 | astrocyte activation(GO:0048143) |
0.0 | 0.1 | GO:0061042 | vascular wound healing(GO:0061042) |
0.0 | 0.0 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.0 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.0 | 0.0 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.0 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.2 | GO:0071435 | potassium ion export(GO:0071435) |
0.0 | 0.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.1 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.0 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.0 | 0.1 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.0 | 0.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.1 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.0 | 0.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.1 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.0 | 0.1 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.9 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.0 | 0.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.2 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.0 | 0.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.0 | 0.0 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.0 | 0.0 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.0 | 0.0 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.0 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.0 | 0.0 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 0.1 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.0 | 0.0 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.1 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.2 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.0 | 0.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.0 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.0 | 0.1 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.0 | 0.0 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.0 | 0.1 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.0 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.0 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.5 | GO:0042471 | ear morphogenesis(GO:0042471) |
0.0 | 0.0 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) regulation of collateral sprouting in absence of injury(GO:0048696) |
0.0 | 0.1 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.0 | 0.1 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.0 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.0 | 0.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.0 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.0 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.1 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.1 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.1 | GO:0007416 | synapse assembly(GO:0007416) |
0.0 | 0.0 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.0 | 0.0 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.1 | GO:0060384 | innervation(GO:0060384) |
0.0 | 0.0 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.0 | 0.0 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.0 | 0.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.0 | 0.0 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.0 | 0.2 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.0 | 0.2 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.1 | GO:0051324 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.0 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.0 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.0 | 0.3 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.0 | 0.0 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.0 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.0 | GO:1902913 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.0 | 0.1 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.0 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.0 | 0.0 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.0 | 0.0 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.0 | 0.0 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.0 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.0 | 0.0 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.0 | 0.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.1 | GO:0001810 | regulation of type I hypersensitivity(GO:0001810) type I hypersensitivity(GO:0016068) |
0.0 | 0.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.0 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 | 0.1 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.0 | 0.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.0 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.0 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.0 | 0.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.0 | 0.3 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.0 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
0.0 | 0.0 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.0 | 0.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.0 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.0 | GO:0043584 | nose development(GO:0043584) |
0.0 | 0.0 | GO:0015810 | aspartate transport(GO:0015810) |
0.0 | 0.0 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.0 | 0.1 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.0 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.0 | 0.0 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.0 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.0 | 0.0 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.0 | 0.1 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.0 | 0.0 | GO:0033058 | directional locomotion(GO:0033058) |
0.0 | 0.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.0 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.4 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.2 | 1.6 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 0.5 | GO:0097441 | basilar dendrite(GO:0097441) |
0.2 | 1.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.4 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 1.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.2 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.4 | GO:1990696 | USH2 complex(GO:1990696) |
0.1 | 0.7 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.5 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 0.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 1.8 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.6 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.8 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 1.0 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.1 | 0.3 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.0 | 0.2 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.1 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.0 | 0.4 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.0 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.2 | GO:0071953 | elastic fiber(GO:0071953) |
0.0 | 4.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 0.0 | GO:0044393 | microspike(GO:0044393) |
0.0 | 0.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.2 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 5.0 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.1 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.0 | 0.1 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 1.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 0.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.2 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.0 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.0 | 0.1 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.5 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 0.5 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.0 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 1.5 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.6 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 5.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.0 | 0.1 | GO:0097452 | GAIT complex(GO:0097452) |
0.0 | 0.3 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.0 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.0 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.0 | 0.6 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.2 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.4 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.0 | 0.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.0 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 0.0 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.1 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.1 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.1 | GO:0097433 | dense body(GO:0097433) |
0.0 | 0.0 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.0 | 0.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.0 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.3 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.0 | GO:0032280 | symmetric synapse(GO:0032280) |
0.0 | 3.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.0 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 0.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 0.2 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 0.7 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.1 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.1 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.0 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 2.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.3 | 1.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.3 | 2.0 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 0.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.2 | 0.7 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.2 | 0.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.2 | 1.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.2 | 0.8 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 0.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 1.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.1 | 0.4 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 0.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 1.1 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.6 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 0.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 1.2 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.4 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 0.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.4 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.3 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 0.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.2 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 0.1 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.1 | 0.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 1.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.2 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 1.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.1 | 0.4 | GO:0034785 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.1 | 0.2 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.5 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 1.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 1.0 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 0.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 0.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 2.2 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.4 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.6 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.6 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 1.2 | GO:0044688 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.0 | 0.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.0 | 0.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 1.1 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.4 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.5 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.4 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.0 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.1 | GO:0015556 | L-aspartate transmembrane transporter activity(GO:0015183) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.0 | 0.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 0.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.0 | 0.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 0.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.4 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.0 | 0.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.2 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.0 | 0.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 0.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.1 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.2 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.0 | 0.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 0.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.0 | 0.5 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.0 | 0.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.0 | 0.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.0 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.0 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.1 | GO:0045340 | mercury ion binding(GO:0045340) |
0.0 | 0.1 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.0 | 0.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.0 | 0.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.1 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.0 | 0.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.0 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.0 | 0.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 0.1 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.3 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.3 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.1 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.0 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.1 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.0 | 0.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.1 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.0 | 0.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.0 | 0.1 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.0 | 0.1 | GO:0097001 | ceramide binding(GO:0097001) |
0.0 | 1.6 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.1 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.0 | 0.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.0 | 0.0 | GO:0048030 | disaccharide binding(GO:0048030) |
0.0 | 0.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.1 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.0 | 0.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.0 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.0 | 0.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 12.1 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.0 | 0.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.0 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 0.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.1 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.0 | 0.0 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.0 | 0.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.1 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.1 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.0 | 0.2 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.4 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.0 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.0 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.0 | 0.1 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.0 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.1 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 0.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.0 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.0 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.0 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.0 | 0.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.0 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.0 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.0 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.3 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 0.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 1.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 1.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 2.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 2.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 1.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 1.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 1.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 0.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 1.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.1 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.1 | 0.6 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 1.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 1.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.6 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.0 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 0.6 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.2 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.0 | 0.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 1.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 1.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.6 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.5 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.1 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 0.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.1 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.0 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.0 | 0.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.0 | 0.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.3 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |